EX-10.76



 Exhibit 10.76 
 CONSULTING AGREEMENT 
 THIS CONSULTING
AGREEMENT (“Agreement”) is entered into as of March 29, 2013, by and between Solutio Partners (“Consultant”) and Dynavax Technologies Corporation (“Dynavax”). 

Dynavax desires that Consultant provide Dynavax with consulting services relating to areas formerly under his supervision in his position as Vice
President Global Technical Operations, and Consultant desires to provide such consulting services. 
 Now,
THEREFORE, in consideration of the foregoing and the mutual covenants and agreements set forth herein, and for other good and valuable consideration, the receipt of which is hereby acknowledged, the parties agree as follows:

 1. ENGAGEMENT OF SERVICES. Effective as of the date hereof,
Consultant will be retained by Dynavax to provide the services described on Exhibit A (“Services”). Consultant agrees to make available Stephen Tuck to provide the Services at such times and locations as reasonably required by Dynavax, for
the amount of time specified in Exhibit A or otherwise as necessary to perform the Services pursuant to this Agreement Consultant agrees to exercise the highest degree of professionalism in providing the Services and to perform the Services in a
timely manner consistent with industry standards. 
 2. FEES AND
TAXES. Consultant shall be paid fees for the Services as described in Exhibit A. Consultant will be eligible for reimbursement for all reasonable travel expenses incurred when associated with the rendering of Services at locations
away from his home area, subject to the prior written approval of Dynavax. Consultant shall be solely responsible for all other expenses incurred in the performance of Services under this Agreement. 

Dynavax shall reimburse Consultant within thirty (30) days of receipt of an invoice listing permitted expenses actually incurred, including receipts
for expenses in excess of $25. Dynavax will not be obliged to pay any invoice that is received more than six months after the date of incurrence. 
 Because Consultant Is an independent contractor, Dynavax will not withhold or make payments for state or federal income tax or Social Security; make unemployment insurance or disability insurance
contributions; or obtain workers’ compensation insurance on Consultant’s behalf (except as required by law). All payments, including reimbursements for actual expenditures, shall be included in gross income as compensation for services
rendered and reported on an IRS Form 1099 Dynavax will provide to you. 
 Consultant agrees to accept exclusive liability for complying with all
applicable state and federal laws governing self-employed individuals and other contributions based on the fees paid to Consultant, its agents, or employees under this Agreement. Consultant hereby indemnifies and defends Dynavax against any and all
such taxes or contributions. 
 3. CONSULTANT NOT AN
EMPLOYEE. It is the express intention of both Consultant and Dynavax that Consultant is an independent contractor and not an employee, agent, joint venturer, or partner of Dynavax. It is further understood that Consultant is
retained and has contracted with Dynavax only for the purposes and to the extent set forth in this Agreement, and Consultant’s relation to Dynavax shall, during the period of Service, be that of an independent contractor, and Contractor shall
be free to dispose of such portion of his entire time, energy, and skill as is not obligated to be devoted to Dynavax 

  
 Page 1









 
in such manner he sees fit and to such persons, firms, or corporations as he deem advisable, so long as same does not create a conflict of interest between Dynavax and such other persons, firms,
or corporations. 
 The manner and means by which Consultant chooses to complete the Services are in Consultant’s sole discretion and
control and at a location, place, and time which the Consultant deems appropriate. Consultant will, at Consultant’s sole expense, provide equipment, tools, and other materials required to perform the Services, unless otherwise provided by
Dynavax in its discretion and Dynavax will make its facilities and equipment available to Consultant as necessary. Consultant agrees not to give any person or entity any reason to believe that Consultant is an employee, agent, joint venturer, or
partner of Dynavax. Consultant agrees not to bind Dynavax, unless expressly authorized by Dynavax in writing. Consultant will not receive any employee benefits such as paid holidays, vacations, sick leave, or other such paid time off and shall not
be entitled hereafter to participate in any plans, arrangements, or distributions by Dynavax relating to any pension, deferred compensation, bonus, stock option, health or other insurance, or other benefits extended to its employees. 

4. PROPRIETARY INFORMATION AND INVENTIONS. Consultant agrees to
execute and comply with the Consultant Proprietary Information and Inventions Agreement and/or Non-Disclosure Agreement entered into between Dynavax and Consultant in connection herewith, and that a material breach of such agreement shall constitute
a material breach hereunder. 
 5. TERMINATION. This Agreement shall be effective as of the date hereof
and shall continue until September 30, 2013 (“Term”), unless terminated earlier as set forth in this paragraph. Dynavax may terminate the Agreement immediately upon notice and payment of the portion of the Consultant’s fee
provided in Exhibit A equivalent to the percentage completion of the Term. Either party may terminate except for breach effective following notice and expiration of a 30 day period to remedy the asserted breach. 

6. ARBITRATION. Any controversy, dispute or claim arising out of, in connection with, or in relation to the
interpretation or performance of this Agreement shall be resolved through binding and nonappealable arbitration administered by the Judicial Arbitration & Mediation Services, Inc. (“JAMS”) in San Francisco County, California. Any
such arbitration shall be conducted before a single arbitrator to be appointed by the parties from JAMS’ roster. If the parties fail to agree to as to the identity of the single arbitrator, JAMS shall have the right to make such appointment.
The conduct of the arbitration hearing and discovery prior thereto shall be in accordance with the California Code of Civil Procedure, California Rules of Court, and California Rules of Evidence. There shall be limited discovery prior to the
arbitration hearing, subject to the discretion of the arbitrator, as follows: (a) exchange of witness lists and copies of documentary evidence and documents related to or arising out of the issues to be arbitrated, (b) depositions of all
party witnesses, and (c) such other depositions as may be allowed by the arbitrator upon a showing of good cause. The nonprevailing party shall pay the prevailing party’s costs and expenses (including attorneys’ fees) of any such
arbitration. Consultant and Dynavax shall bear equally the fees and expenses of the arbitrator. The arbitrator shall decide the matter to be arbitrated pursuant hereto within 60 days after the appointment of the arbitrator. 

7. GENERAL. Consultant agrees not to engage in any employment or activity (whether as a consultant, advisor or
otherwise) in any business directly competitive with Dynavax during the term of this Agreement, without Dynavax’s express written consent. 

  
 Page 2









 Consultant agrees not to (i) call upon, solicit, divert or take away or attempt to solicit, divert or
take away any of the customers, business or patrons of Dynavax; or (ii) employ, solicit or attempt to solicit for employment any person who is then an employee of or consultant to Dynavax or who was an employee of or consultant to Dynavax for a
period of one (1) year following expiration of this Agreement. 
 If any provision of this Agreement shall be declared Invalid, illegal or
un-enforceable, such provision shall be severed and all remaining provisions shall continue in full force and effect 
 The term, Dynavax, as
used herein, shall include any subsidiary or affiliate of Dynavax Technologies Corporation. 
 This Agreement shall be binding upon Consultant,
his heirs, executors, assigns and administrators and shall inure to the benefit of Dynavax, its successors and assigns and shall not, and nor is it intended to be, for the benefit of any other party. 

This Agreement shall replace as of the Effective Date any prior agreement between Consultant and Dynavax relative to services as a consultant, and this
Agreement contains the entire understanding of the parties. Further, it shall be amended only in writing agreed to by both parties and shall not be assignable by Consultant. 
 This Agreement is entered into without relying upon any promise, warranty, or representation, written or oral, other than those expressly contained in this Agreement, and it supersedes any other such
promises, warranties, representations, or agreements. This Agreement may not be amended or modified except by a written instrument signed by both Consultant and a duly authorized officer of Dynavax. This Agreement shall be construed and interpreted
In accordance with the laws of the State of California, as such laws are applied to contracts executed and performed entirely within California. 
 IN WITNESS WHEREOF, the parties hereto have executed this Agreement as of the date first written above. 

 

									
	AGREED TO:	 		 	AGREED TO:
			
	Dynavax Technologies Corporation	 		 	Solutio Partners
					
	By:	 	 /s/ David Novack
	 		 	By:	 	 /s/    Stephen
Tuck        

		 	David Novack	 		 		 	Stephen Tuck
					
	Date:	 	 02 April 2013
	 		 	Date:	 	 02 APRIL 2013

			
	Dynavax Technologies	 		 	
	2929 Seventh Street, Suite 100	 		 	[Personal ADDRESS]
	Berkeley, CA 94710	 		 	
	Telephone: 510-665-7202	 		 	
	Email: dnovack@dynavax.com	 		 	


  
 Page 3









 EXHIBIT A 
 SERVICES; FEE 
 Consultant will provide strategic advice,
knowledge, skills, information and experiences in the areas formerly under his supervision as Vice President Global Technical Operations. 
 As
an advisor, he will review, provide feedback/comments and if needed write sections for the asthma CTA, FDA CRL, and 120 day questions from EMA. 

Upon satisfactory completion of the Services on September 30, 2013, subject to paragraph 5 of the Agreement, consultant will be paid a lump sum
payment of $350,000. 

  
 Page 4